Literature DB >> 10960774

Stem cell factor and IL-6 do not promote complete maturation of human cultured mast cells from umbilical cord blood cells: an ultrastructural study.

Y Matsushima1, O Ishikawa, M Kurosawa, Y Miyachi.   

Abstract

Human mast cells are classified into two phenotypes based on their neutral protease compositions. One type is a tryptase-positive and chymase-positive MCTC cell that is predominant in the skin, another is a tryptase-positive and chymase-negative MCT cell that is predominant in the lung. Cord blood-derived human mast cells cultured in the presence of stem cell factor and interleukin-6 are a mixture of MCTC and MCT at various ratios, as revealed by immunocytochemical staining. We performed an electron microscopic analysis of cord blood-derived human cultured mast cells and found that they were so immature that we could not distinguish MCT and MCTC from their ultrastructural morphology. The response to secretagogues was not the response of MCTC but rather of MCT. Although human cultured mast cells are the most useful cells for use in in vitro experiments, the present culture condition supplemented with stem cell factor and interleukin-6 does not develop fully mature mast cells in vitro.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960774     DOI: 10.1016/s0923-1811(00)00076-1

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  2 in total

1.  Human embryonic stem cells: a source of mast cells for the study of allergic and inflammatory diseases.

Authors:  Martina Kovarova; Anne M Latour; Kelly D Chason; Stephen L Tilley; Beverly H Koller
Journal:  Blood       Date:  2010-03-03       Impact factor: 22.113

2.  Molecular Characterization and Biological Function of a Novel LncRNA CRNG in Swine.

Authors:  Qirong Lu; Li Li; Aixin Huang; Luqing Cui; Yinfeng Zhang; Qianying Liu; Xu Wang; Yulian Wang; Zhenli Liu; Zonghui Yuan; Menghong Dai
Journal:  Front Pharmacol       Date:  2019-05-21       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.